Published in

Wiley, FEBS Letters, 12(584), p. 2662-2669, 2010

DOI: 10.1016/j.febslet.2010.04.002

Links

Tools

Export citation

Search in Google Scholar

The molecular signature of oncofusion proteins in acute myeloid leukemia

Journal article published in 2010 by Joost H. A. Martens ORCID, Henk G. Stunnenberg
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Acute myeloid leukemia (AML) associated translocations often cause gene fusions that encode oncofusion proteins. Although many of the breakpoints involved in chromosomal translocations have been cloned, in most cases the role of the chimeric proteins in tumorigenesis is not elucidated. Here we will discuss the fusion proteins of the 4 most common translocations associated with AML as well as the common molecular mechanisms that these four and other fusion proteins utilize to transform progenitor cells. Intriguingly, although the individual partners within the fusion proteins represent a wide variety of cellular functions, at the molecular level many commodities can be found.